At Hifas Biologics, we are excited to share one of our most recent and significant achievements: we have been selected to participate in the Biotech Startups Acceleration Programme, a collaborative initiative of the EOI Foundation and the Ministry of Industry, Trade and Tourism. This is an exclusive programme, designed specifically for biotech startups like ours, which is led by Science & Innovation Link Office (SILO) in association with AseBio – Spanish Association of Biocompanies, and is backed by major specialised investment funds.
Being part of the Biotech Startup Acceleration Programme represents an unparalleled opportunity for us. This programme gives us access to world-class mentors and speakers who will explore critical aspects of the biotech industry. Here are some of the benefits we will gain from this great opportunity!
Technology Transfer Strategies: We will learn how to refine our technology transfer strategies, ensuring that our innovations in the use of fungi to develop new antibiotics efficiently reach the market.
Robust Business Models: We will work on creating robust business models that allow us to scale and sustain our growth in the competitive biotech sector.
Funding and Investment: Navigating the funding and investment landscape is crucial for any startup. This programme will provide us with the tools and knowledge necessary to attract investors and secure the resources we need to move forward.
Intellectual Property Protection: Intellectual property is a vital component of our strategy. We will learn how to effectively protect our innovations and ensure that our discoveries are safe from competition.
Business Development: We will foster business development opportunities that expand our networks and strengthen our collaborations within the biotech industry.
La participación en este programa representa un hito significativo en nuestro viaje como startup. Nos encontramos en un momento crucial donde cada aprendizaje y cada conexión tiene un gran impacto en nuestra misión de mejorar el estado de la salud global y enfrentar la amenaza antimicrobiana. Por ello, estamos increíblemente emocionados por las posibilidades que este programa nos ofrece y nos encontramos preparados para aprovechar cada oportunidad que se nos presente. Este es un paso adelante hacia la consecución de nuestra visión de mejorar la salud global mediante la biotecnología avanzada y sostenible.
Agradecemos a la Fundación EOI, al Ministerio de Industria, Comercio y Turismo, a SILO y a AseBio por esta increíble oportunidad. Estamos ansiosos por comenzar esta emocionante etapa y compartir nuestros progresos con nuestra comunidad y el mundo. ¡Síguenos en esta etapa y descubre cómo estamos transformando la industria biotecnológica!